Gennao Bio, Juno Diagnostics Break Onto the Scene With Combined $65 Million

Gennao Bio and Juno Diagnostics, two biopharma companies, raised a combined $65 million in Series A funding rounds. The Series A rounds are the latest in a string of financing announcements made over the past few months.